Answers are grounded in this paper and cite their sources.
This AHA scientific statement highlights the need for cardiovascular clinicians to improve their genetic literacy to effectively integrate genomic advances into patient care.
Advances in genomics are enhancing our understanding of the genetic basis of cardiovascular diseases, both congenital and acquired, and stroke. These advances include finding genes that cause or increase the risk for childhood and adult-onset diseases, finding genes that influence how patients respond to medications, and the development of genetics-guided therapies for diseases. However, the ability of cardiovascular and stroke clinicians to fully understand and apply this knowledge to the care of their patients has lagged. This statement addresses what the specialist caring for patients with cardiovascular diseases and stroke should know about genetics; how they can gain this knowledge; how they can keep up-to-date with advances in genetics, genomics, and pharmacogenetics; and how they can apply this knowledge to improve the care of patients and families with cardiovascular diseases and stroke.
No takes yet. Share an insight, caveat, or question.
Mital et al. (2016) conducted a review in Cardiovascular diseases and stroke. This scientific statement outlines what cardiovascular and stroke specialists should know about genetics, how to gain and maintain this knowledge, and how to apply it to patient care.
Synapse has enriched 10 related papers. Consider them for comparative context: